Sertraline Hydrochloride
Product Images NDC 70934-169

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Sertraline Hydrochloride (NDC 70934-169). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

70934 169 90 Master Bottle Label Approval Rev B 01 19

Label for Sertraline Hydrochloride Tablets USP 50 mg, containing 90 tablets. The label includes dosage instructions, storage conditions, and safety warnings. It specifies prescription use only and provides batch numbers, manufacturing, and expiration dates. The product is labeled by Denton Pharma, Inc. DBA Northwind Pharmaceuticals with NDC 70934-169.*

FDA Label Image

Chemical Structure (Sertraline Str)

Chemical structure of sertraline hydrochloride showing its two chlorinated phenyl rings and hydrochloride salt form, associated with the active ingredient in SERTRALINE HYDROCHLORIDE by Denton Pharma, Inc. DBA Northwind Pharmaceuticals (NDC 70934-169).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.